A detailed history of Credit Suisse Ag transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Credit Suisse Ag holds 199,920 shares of DVAX stock, worth $2.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
199,920
Previous 200,134 0.11%
Holding current value
$2.28 Million
Previous $2.8 Million 11.3%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$11.7 - $14.98 $2,503 - $3,205
-214 Reduced 0.11%
199,920 $2.48 Million
Q4 2023

Feb 08, 2024

BUY
$13.09 - $14.98 $8,914 - $10,201
681 Added 0.34%
200,134 $2.8 Million
Q3 2023

Nov 13, 2023

SELL
$12.64 - $14.99 $198,106 - $234,938
-15,673 Reduced 7.29%
199,453 $2.95 Million
Q2 2023

Aug 11, 2023

BUY
$9.85 - $13.17 $236,941 - $316,804
24,055 Added 12.59%
215,126 $2.78 Million
Q1 2023

May 10, 2023

BUY
$9.44 - $11.88 $78,975 - $99,388
8,366 Added 4.58%
191,071 $1.87 Million
Q4 2022

Feb 13, 2023

BUY
$10.27 - $13.29 $234,289 - $303,184
22,813 Added 14.27%
182,705 $1.94 Million
Q3 2022

Nov 10, 2022

SELL
$9.93 - $17.44 $27,486 - $48,273
-2,768 Reduced 1.7%
159,892 $1.67 Million
Q2 2022

Aug 12, 2022

SELL
$7.45 - $12.83 $127,164 - $218,995
-17,069 Reduced 9.5%
162,660 $2.05 Million
Q1 2022

May 16, 2022

BUY
$9.75 - $14.44 $239,333 - $354,458
24,547 Added 15.82%
179,729 $1.95 Million
Q4 2021

Feb 14, 2022

BUY
$13.17 - $20.94 $46,002 - $73,143
3,493 Added 2.3%
155,182 $2.18 Million
Q3 2021

Nov 12, 2021

BUY
$9.16 - $19.83 $80,406 - $174,067
8,778 Added 6.14%
151,689 $2.92 Million
Q2 2021

Aug 16, 2021

BUY
$7.25 - $10.99 $266,169 - $403,475
36,713 Added 34.57%
142,911 $1.41 Million
Q1 2021

May 14, 2021

SELL
$4.57 - $11.18 $1.04 Million - $2.54 Million
-227,121 Reduced 68.14%
106,198 $1.04 Million
Q4 2020

Feb 12, 2021

SELL
$3.73 - $5.6 $700,874 - $1.05 Million
-187,902 Reduced 36.05%
333,319 $1.48 Million
Q3 2020

Nov 13, 2020

BUY
$4.32 - $11.7 $1.19 Million - $3.21 Million
274,520 Added 111.28%
521,221 $2.25 Million
Q2 2020

Aug 12, 2020

BUY
$2.94 - $9.1 $411,864 - $1.27 Million
140,090 Added 131.4%
246,701 $2.19 Million
Q1 2020

May 13, 2020

SELL
$2.27 - $6.2 $33,872 - $92,516
-14,922 Reduced 12.28%
106,611 $376,000
Q4 2019

Feb 12, 2020

BUY
$3.46 - $6.93 $238,463 - $477,615
68,920 Added 130.99%
121,533 $696,000
Q3 2019

Nov 12, 2019

BUY
$2.69 - $4.85 $22,265 - $40,143
8,277 Added 18.67%
52,613 $187,000
Q2 2019

Aug 14, 2019

BUY
$3.65 - $7.89 $13,461 - $29,098
3,688 Added 9.07%
44,336 $176,000
Q1 2019

May 14, 2019

BUY
$7.08 - $12.09 $39,825 - $68,006
5,625 Added 16.06%
40,648 $298,000
Q4 2018

Feb 13, 2019

BUY
$8.14 - $13.28 $76,662 - $125,071
9,418 Added 36.78%
35,023 $321,000
Q3 2018

Nov 13, 2018

SELL
$11.85 - $16.0 $1.19 Million - $1.6 Million
-100,048 Reduced 79.62%
25,605 $318,000
Q2 2018

Aug 14, 2018

SELL
$15.15 - $20.75 $72,265 - $98,977
-4,770 Reduced 3.66%
125,653 $1.92 Million
Q1 2018

May 15, 2018

BUY
$14.65 - $19.9 $648,013 - $880,236
44,233 Added 51.32%
130,423 $2.59 Million
Q4 2017

Feb 14, 2018

SELL
$17.3 - $24.08 $2.22 Million - $3.09 Million
-128,238 Reduced 59.8%
86,190 $1.61 Million
Q3 2017

Nov 14, 2017

BUY
$15.2 - $21.5 $2.55 Million - $3.6 Million
167,506 Added 356.99%
214,428 $4.61 Million
Q2 2017

Aug 14, 2017

BUY
N/A
46,922
46,922 $452,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.44B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.